Submission packages—such as drug master files for active ingredients—are pre-validated by an AI engine, allowing companies to ...

This episode of Pharma Pulse discusses how the FDA’s new plausible mechanism pathway, WeightWatchers’ plans to offer oral Wegovy, and emerging evidence on berberine are shaping the future of obesity ...

Following LogiPharma USA 2025, the editors of Pharmaceutical Commerce explore the latest trends and key takeaways from the event, with a focus on the cold chain solutions sector.

In third part of his Pharma Commerce video interview, Faisal Khan, a GRC solutions expert with Vanta, emphasizes the need for ...

This comes during a time when when Eli Lilly and Novo Nordisk have been garnering momentum—last week, the FDA added ...

DSCSA compliance is only the beginning. Is your warehouse ready for the challenges it brings? Without the right strategies in place, compliance can create bottlenecks, delay shipments, and lead to ...

This episode of Pharma Pulse discusses how Dr. Richard Pazdur’s appointment signals a new era for FDA drug evaluation, why hospitals are opposing the government’s 340B pilot program, and how Novartis ...

PC: What hurdles typically come with moving from manual spreadsheets to AI-powered orchestration, especially when taking the ...

Novartis has unveiled a 10,000-square-foot radioligand therapy (RLT) production plant in Carlsbad, CA, representing a move ...

This episode of Pharma Pulse explores how regulators modernize safety information for hormone therapy, new data that ...

In the first part of her Pharma Commerce video interview, Christy Christian, senior industry principal with Kinaxis, describes how manufacturers face mounting challenges managing long, complex supply ...